TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) has 16 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 22, 2026.
Insiders have net sold $12.7M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Richard D. Francis
- Employees:37,000
- HQ:Tel Aviv, IL
- IPO:1982-02-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.7M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$36.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP, Global Operations | Sale | 9,989 | $322K | Jun 22 | SEC ↗ | |
| EVP, Chief Financial Officer | Sale | 106,563 | $3.6M | Jun 16 | SEC ↗ | |
Francis Richard DFirst filing | President and CEO | Sale | 6,153 | $211K | Jun 8 | SEC ↗ |
Shields MatthewFirst filing | EVP, Global Operations | Sale | 16,195 | $532K | Jun 4 | SEC ↗ |
Lippman EvanFirst filing | EVP, Business Development | Sale | 41,658 | $1.5M | May 18 | SEC ↗ |
Kalif Eliyahu SharonFirst filing | EVP, Chief Financial Officer | Sale | 153,251 | $5.5M | May 18 | SEC ↗ |
Daniell RichardFirst filing | EVP, Europe Commercial | Sale | 30,000 | $1.1M | May 7 | SEC ↗ |
Related companies
TEVA PHARMACEUTICAL INDUSTRIES LTD is in the Healthcare sector.